CD79A and celiac disease: The prevalence of celiac disease in our study (11.5% with elevated TTG-IgA; 7.7% ultimately diagnosed with celiac disease) was significantly higher than the rates reported by Yodoshi et al (0.4%)16 and Schwimmer et al (1.2%).15 Only half (54.7%) of our cohort had celiac testing even performed.